April 21, 2011
By Tanya Pollitt
On Friday, April 22, 2011, at 2:00 p.m., Safeway employees at the 6220 E.14th Ave. location, will give $350,000 to the University of Colorado Cancer Center toward the efforts of breast cancer research.
A clinical trial, the I-SPY2 TRIAL(Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) will be supported by this gift. The goal is to speed up studies of new treatments, focusing on specific subtypes of breast cancer.
The I-SPY2 TRIAL is a clinical trial that aims to answer a specific question: which is the better of two kinds of treatment for women who have been newly diagnosed with locally advanced breast tumors: chemotherapyor chemotherapy plus “new biologically targeted therapies”.
Both treatments would be followed with surgery.
Safeway, Inc. has given the University of Colorado Cancer Center more than $1 million over the last four years toward critical breast cancer research.
The University of Colorado Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in the Rocky Mountain region.
The Center is partnered with the University of Colorado Hospital and The Children’s Hospital and has its headquarters on the Anschutz Medical Campus. It is a combined entity consisting of three state universities and five institutions.
To read more about the I-SPY2 TRIAL, go to http://ispy2.org.
attributions: CU news via Erica Matich.